Explore
Trendline
Halia Therapeutics Expands Board with New Executive Chairman and Directors Amid Strategic Growth
Halia Therapeutics Expands Board with New Executive Chairman and Directors Amid Strategic Growth
Read More
Trendline
Enveric Biosciences Reports Q1 2026 Financial Results and Advances Lead Drug Candidate
Enveric Biosciences Reports Q1 2026 Financial Results and Advances Lead Drug Candidate
Read More
Trendline
Oligomerix Completes Phase 1a Study of Alzheimer's Drug OLX-07010, Showing Promise for Future Trials
Oligomerix Completes Phase 1a Study of Alzheimer's Drug OLX-07010, Showing Promise for Future Trials
Read More
Trendline
Bronstein, Gewirtz Grossman, LLC Files Class Action Lawsuit Against Immutep Limited for Securities Violations
Bronstein, Gewirtz Grossman, LLC Files Class Action Lawsuit Against Immutep Limited for Securities Violations
Read More
Trendline
Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical Lead
Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn as Executive Clinical Lead
Read More
Trendline
Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn to Lead Clinical and Regulatory Strategy
Turn Therapeutics Appoints Former FDA Commissioner Dr. Stephen M. Hahn to Lead Clinical and Regulatory Strategy
Read More
Trendline
Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth
Sensei Biotherapeutics Advances Cancer Treatment Trials with PIKTOR, Reports Financial Growth
Read More
Trendline
AI in Biotechnology: Transforming Drug Discovery and Personalized Medicine
AI in Biotechnology: Transforming Drug Discovery and Personalized Medicine
Read More
Trendline
FDA Alignment and AI Integration Crucial for Rare Disease Treatment Advancements
FDA Alignment and AI Integration Crucial for Rare Disease Treatment Advancements
Read More
Trendline
Contineum Therapeutics Grants Stock Options to New Employee Under Nasdaq Rule
Contineum Therapeutics Grants Stock Options to New Employee Under Nasdaq Rule
Read More
Trendline
Faruqi Faruqi, LLP Alerts Immutep Investors of Securities Class Action Deadline
Faruqi Faruqi, LLP Alerts Immutep Investors of Securities Class Action Deadline
Read More
Trendline
Bristol Myers Squibb Expands Oncology Pipeline with Lonza Licensing Deal
Bristol Myers Squibb Expands Oncology Pipeline with Lonza Licensing Deal
Read More